fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    2.1% to 2.6% of patients given Qnexa (phentermine + Topamax) dropped out due to cognitive effects


    Posted by .(JavaScript must be enabled to view this email address)
    Thursday, October 29, 2009 1:42 pm Email this article
    Among patients given a full dose of Qnexa (15 mg Phentermine plus 92 mg Topamax), 2.1% and 2.6% dropped out of two study due to cognitive side effects such as "disturbance in attention" or "forgetfulness" compared to 0.3% and 0.8% of those given the placebo reports TheStreet.com.

    This had not been previously disclosed by Vivus, the company developing this drug.

    Other articles about Qnexa are posted here.

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.